Search Results for: STEM CELL MARKET Stem Cell
Articles
Cellular Origins & Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell & Gene Therapy Manufacturing October 16, 2024
Cellular Origins and Fresenius Kabi, an operating company of Fresenius, recently announced they have signed a development agreement that leverages...Evonik Establishes Global Competence Network for Cell Culture Solutions October 2, 2024
Evonik has established a new global network to develop system solutions that address upstream challenges in cell culture. The Global...GRI Bio Granted Patent for Proprietary Natural Killer T Cell Modulators for Prevention & Treatment of Inflammatory Conditions September 30, 2024
GRI Bio, Inc. recently announced it has received a Decision to Grant notice from the Japan Patent Office (JPO) for...GoLiver Therapeutics Awarded Innovation in Biotherapies & Bioproduction Call for its GOCLINICALS Project Dedicated to Novel Stem Cell-Based Liver Therapy September 25, 2024
GoLiver Therapeutics recently announced it has won the Innovations in Biotherapies and Bioproduction call for proposal launched by the French...Ingenza Announces Partnership With Cellugy to Investigate the Potential of Biofabricated Cellulose August 22, 2024
Industrial biotech specialist Ingenza recently announced it is collaborating with Cellugy to accelerate the development of its innovative platform for...ANEW MEDICAL Announces Patents Issued in Major Asian Markets for Use of Genetic Therapy August 8, 2024
ANEW MEDICAL, INC. recently announced the grant and issuance of patent number HK1259628 protecting the development of novel genetic approaches...Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates July 29, 2024
Pluri Inc. recently announced it has signed a tech transfer and manufacturing agreement with Kadimastem Ltd., a clinical stage biotechnology...Cellular Origins Acquires ACTIA Platform IP to Enhance Automated Cell Therapy Manufacturing July 2, 2024
Cellular Origins recently announced the acquisition of the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge...Bio-Rad Launches ddSEQ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression June 19, 2024
Bio-Rad Laboratories, Inc. recently announced the launch of the ddSEQ Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software...Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma May 30, 2024
Elevar Therapeutics, Inc. recently announced the landmark overall survival (OS) analysis of camrelizumab and rivoceranib as a first-line treatment for...Limula Raises $6.8M to Democratise Access to Life-Saving Cell & Gene Therapies With Swiss-Made Manufacturing Platform May 21, 2024
Over the past decade, several breakthrough Cell and Gene Therapy products have been approved in the US and Europe to...CELL & GENE THERAPY - It’s Time to Build Infrastructure to Handle the Coming Surge April 30, 2024
Fran Gregory says the complexities and innovations associated with the production of cell and gene therapies also necessitates a shift in infrastructure, which will affect manufacturers, distributors, and providers. From development, manufacturing, storage, and delivery to patients; each step in the process requires forging a new path.
Kincell Bio & Imugene Announce Strategic Manufacturing & Process Development Partnership April 16, 2024
Kincell Bio to acquire Imugene’s North Carolina manufacturing facility for up to $6M USD in upfront and milestone-driven payments over 3 years….
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion Into Autoimmune Diseases March 28, 2024
Mustang Bio, Inc. recently announced its expansion into autoimmune diseases with MB-106, a personalized CD20-targeted, 3rd-generation autologous CAR T-cell therapy....Bio-Rad Launches Validated Antibodies for Rare Cell & Circulating Tumor Cell Enumeration March 26, 2024
Bio-Rad Laboratories, Inc. recently announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated...Sequel’s twiist Automated Insulin Delivery System Receives FDA 510(k) Clearance March 18, 2024
Device bundles latest technology to deliver significant advancements for insulin management for people with type 1 diabetes….
GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T Cell Modulators March 14, 2024
GRI Bio, Inc. recently announced the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for Patent Application...ABVC's New Horizon for Oncology & Hematology Aims at Cancer Market of Several Hundred Billion Dollars February 27, 2024
ABVC BioPharma, Inc. recently provided an update on its development of combination therapy for the treatment of cancer and immunity booster dietary supplements. The company is currently marketing….
Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating its Next-Generation Vaccine Candidates Elicit Mucosal & Systemic Immunogenicity & Reduce Viral Shedding After SARS-CoV-2 Challenge February 5, 2024
Vaxart, Inc. recently announced the publication of preclinical non-human primate data demonstrating the potential of its COVID-19 vaccine to protect...Credence MedSystems Announces a Significant Milestone Toward Scaling Manufacturing Capabilties January 17, 2024
Credence MedSystems recently announced it has successfully completed Factory Acceptance Testing (FAT) for production of its Companion® injection device platform on the company’s new Clinical Assembly Line…..